Thus, this brief research article aimed to evaluate whether alterations in the gene expression of matrix metalloproteinases-2 (MMP2) and tissue inhibitor of metalloproteinases 2 (TIMP2) whose regulation is altered in adipose tissue in obesity are equally manifested in PBMC, before and after RYGB, and the association of these genes with weight loss and body composition. The gene discussed is TIMP2; the disease is Obesity.